Trial Profile
A Phase IV, Randomized, Double-Blind, Placebo-Controlled, Single-Center Study of the Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Laparoscopic Prostatectomy )
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2023
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary)
- Indications Detrusor instability; Overactive bladder
- Focus Adverse reactions
- 24 Apr 2020 Status changed from active, no longer recruiting to completed.
- 31 Jul 2017 Status changed from completed to active, no longer recruiting.
- 17 Aug 2012 New trial record